Gilead and Galapagos Announce TORTUGA Phase 2 Study of Filgotinib in Ankylosing Spondylitis Achieves Primary Endpoint Read more
LEO Pharma Closes Acquisition of Bayer’s Prescription Dermatology Business in the United States Read more
Novartis to divest the Sandoz US dermatology business and generic US oral solids portfolio to Aurobindo Read more
WuXi AppTec Partner Hutchison MediPharma Receives Approval of Fruquintinib Capsules in China Read more
Atara Biotherapeutics and Moffitt Cancer Center Announce Strategic Collaboration to Develop Next-Generation CAR T Immunotherapies Read more
Thrombolytic Science Initiates Phase 2 Clinical Trial of its Novel Treatment Regimen for Ischemic Stroke Read more